Solvay SA

Industry

  • Pharmaceuticals
    • Vaccines

Other Names/Subsidiaries

  • Laboratories Ireland Ltd.
  • Innogenetics nv
See more in Biomedtracker

Latest on Solvay SA

Scrip

Deal Watch: OrsoBio Reveals Its Metabolic Health Focus With Four Licensing Pacts

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. OrsoBio Splurges With Four Concurrent L

Scrip

Tracing Cipla’s Interest In Vaccines, Potential For Tie-Up With Moderna

 
• By Anju Ghangurde

Is Cipla Limited keen to participate in the COVID-19 vaccines segment? The answer has broadly been a definitive yes, going by recent statements by the company’s senior management, though the scope o

HBW Insight

CIR’s Silica/Silicates Review Could Be First Test Of Panel’s Revised Inhalation Assessment Approach

 
• By Eileen Francis

The Cosmetic Ingredient Review Expert Panel seeks data from industry on particle-size ranges of silica and silicates used in cosmetic sprays and powders, information that’s currently lacking, they say

Generics Bulletin

Impax Defeats FTC Pay-For-Delay Complaint, Helped By Status As Sole Marketer Of Generic Opana ER

 
• By Brenda Sandburg

In dismissing the Federal Trade Commission's pay-for-delay complaint against Impax Laboratories Inc. , the agency's Chief Administrative Law Judge provided clarity as to what patent settlement deals